Clinical Trial

Nicotinamide Riboside in Ulcerative Colitis

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
This was a pilot study only. The primary goal of determining feasibility was achieved. Due to logistical issues and a desire to design a better trial, the study was terminated before reaching enrollment goals.
Summary
This is a randomized, double-blind pilot study of Nicotinamide Riboside (NR) in Pediatric-onset Ulcerative Colitis (UC).
Protocol Amendment History 3 changes
critical Trial terminated 2026-08-11
critical Trial terminated: This was a pilot study only. The primary goal of determining feasibility was achieved. Due to logistical issues and a d... 2026-08-11
notable Enrollment reduced: 40 -> 19 participants 2026-08-11
Trial Details
NCT Number NCT05561738
Lead Sponsor University of Pittsburgh
Collaborators: Crohn's and Colitis Foundation
Conditions Ulcerative Colitis
Enrollment 19 participants
Start Date 2024-02-28
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-10